These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31065907)

  • 1. Immunotherapy in Older Adults with Cancer.
    Godby RC; Johnson DB; Williams GR
    Curr Oncol Rep; 2019 May; 21(7):56. PubMed ID: 31065907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors.
    Hargadon KM; Johnson CE; Williams CJ
    Int Immunopharmacol; 2018 Sep; 62():29-39. PubMed ID: 29990692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Checkpoint inhibitors, the perspectives for elderly patients].
    Landre T; Karaoud F; Taleb C
    Soins Gerontol; 2017; 22(127):30-33. PubMed ID: 28917334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pan-cancer immunogenomic analyses reveal sex disparity in the efficacy of cancer immunotherapy.
    Wang PF; Song HF; Zhang Q; Yan CX
    Eur J Cancer; 2020 Feb; 126():136-138. PubMed ID: 31927214
    [No Abstract]   [Full Text] [Related]  

  • 5. Immune checkpoint inhibitors in cancer treatment and potential effect modification by age.
    Eriksson H; Smedby KE
    Acta Oncol; 2020 Mar; 59(3):247-248. PubMed ID: 32036733
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis.
    Conforti F; Pala L; Bagnardi V; De Pas T; Martinetti M; Viale G; Gelber RD; Goldhirsch A
    Lancet Oncol; 2018 Jun; 19(6):737-746. PubMed ID: 29778737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Immunotherapy in Older Patients.
    Marrone KA; Forde PM
    Cancer J; 2017; 23(4):219-222. PubMed ID: 28731944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventional therapy combined with immune checkpoint inhibitors: Emerging opportunities for cancer treatment in the era of immunotherapy.
    Chang X; Lu X; Guo J; Teng GJ
    Cancer Treat Rev; 2019 Mar; 74():49-60. PubMed ID: 30831375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy in Older Adults: A Checkpoint to Palliation?
    Elias R; Odejide O
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e110-e120. PubMed ID: 31099630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunology and melanoma immunotherapy.
    Linck RDM; Costa RLP; Garicochea B
    An Bras Dermatol; 2017; 92(6):830-835. PubMed ID: 29364441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune checkpoint inhibitors: a narrative review of considerations for the anaesthesiologist.
    Lewis AL; Chaft J; Girotra M; Fischer GW
    Br J Anaesth; 2020 Mar; 124(3):251-260. PubMed ID: 32007241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy.
    Bazhin AV; Amedei A; Karakhanova S
    Front Immunol; 2018; 9():2878. PubMed ID: 30568661
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune Checkpoint Inhibitors in Geriatric Oncology.
    Cook SL; Al Amin M; Bari S; Poonnen PJ; Khasraw M; Johnson MO
    Curr Oncol Rep; 2024 May; 26(5):562-572. PubMed ID: 38587598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A reality check of the accelerated approval of immune-checkpoint inhibitors.
    Gill J; Prasad V
    Nat Rev Clin Oncol; 2019 Nov; 16(11):656-658. PubMed ID: 31383994
    [No Abstract]   [Full Text] [Related]  

  • 15. The Promise of Neoadjuvant Immunotherapy and Surgery for Cancer Treatment.
    O'Donnell JS; Hoefsmit EP; Smyth MJ; Blank CU; Teng MWL
    Clin Cancer Res; 2019 Oct; 25(19):5743-5751. PubMed ID: 31040150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy comes of age: Immune aging & checkpoint inhibitors.
    Elias R; Karantanos T; Sira E; Hartshorn KL
    J Geriatr Oncol; 2017 May; 8(3):229-235. PubMed ID: 28223073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of immunotherapy toxicities in older adults.
    Bhandari S; Gill AS; Perez CA; Jain D
    Semin Oncol; 2018 Aug; 45(4):226-231. PubMed ID: 30446167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy in Older Adults With Advanced Cancers: Implications for Clinical Decision-Making and Future Research.
    Kanesvaran R; Cordoba R; Maggiore R
    Am Soc Clin Oncol Educ Book; 2018 May; 38():400-414. PubMed ID: 30231397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapies for pediatric cancer: current landscape and future perspectives.
    Hutzen B; Paudel SN; Naeimi Kararoudi M; Cassady KA; Lee DA; Cripe TP
    Cancer Metastasis Rev; 2019 Dec; 38(4):573-594. PubMed ID: 31828566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ongoing Phase I Studies of Immune Checkpoint Inhibitors in China.
    Fang W; Zhao S; Zhang Y; Ma Y; Zhao H; Zhang L
    Oncologist; 2019 Feb; 24(Suppl 1):S11-S20. PubMed ID: 30819827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.